Neo Ivy Capital Management Makes New $557,000 Investment in UnitedHealth Group Incorporated (NYSE:UNH)

Key Points

• Neo Ivy Capital Management acquired a new stake of 1,064 shares in UnitedHealth Group, valued at approximately $557,000, highlighting institutional interest in the company.
• UnitedHealth Group recently increased its quarterly dividend from $2.10 to $2.21 per share, reflecting a commitment to returning value to shareholders.
• Analysts have adjusted their ratings and price targets for UnitedHealth Group, with varying recommendations including "hold," "neutral," and "buy", indicating a mixed sentiment among financial experts.

Neo Ivy Capital Management bought a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 1,064 shares of the healthcare conglomerate's stock, valued at approximately $557,000.

Several other hedge funds and other institutional investors have also bought and sold shares of UNH. Financial Management Professionals Inc. boosted its position in shares of UnitedHealth Group by 0.8% during the 1st quarter. Financial Management Professionals Inc. now owns 2,224 shares of the healthcare conglomerate's stock valued at $1,165,000 after acquiring an additional 17 shares during the last quarter. Global Wealth Strategies & Associates boosted its position in UnitedHealth Group by 28.6% during the first quarter. Global Wealth Strategies & Associates now owns 90 shares of the healthcare conglomerate's stock valued at $47,000 after purchasing an additional 20 shares in the last quarter. Kolinsky Wealth Management LLC grew its stake in shares of UnitedHealth Group by 1.0% during the fourth quarter. Kolinsky Wealth Management LLC now owns 2,135 shares of the healthcare conglomerate's stock worth $1,080,000 after acquiring an additional 21 shares during the last quarter. Retirement Planning Group LLC lifted its holdings in UnitedHealth Group by 5.1% in the first quarter. Retirement Planning Group LLC now owns 430 shares of the healthcare conglomerate's stock valued at $225,000 after acquiring an additional 21 shares during the period. Finally, Net Worth Advisory Group increased its position in shares of UnitedHealth Group by 0.6% in the first quarter. Net Worth Advisory Group now owns 3,642 shares of the healthcare conglomerate's stock valued at $1,907,000 after buying an additional 21 shares in the last quarter. Institutional investors own 87.86% of the company's stock.

Insider Activity

In other news, Director Timothy Patrick Flynn acquired 1,533 shares of the firm's stock in a transaction that occurred on Wednesday, May 14th. The shares were acquired at an average cost of $320.80 per share, with a total value of $491,786.40. Following the completion of the purchase, the director directly owned 6,033 shares of the company's stock, valued at $1,935,386.40. The trade was a 34.07% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO John F. Rex purchased 17,175 shares of the business's stock in a transaction dated Friday, May 16th. The shares were acquired at an average price of $291.12 per share, for a total transaction of $4,999,986.00. Following the acquisition, the chief financial officer owned 203,796 shares of the company's stock, valued at $59,329,091.52. This trade represents a 9.20% increase in their position. The disclosure for this purchase can be found here. Over the last three months, insiders acquired 109,408 shares of company stock valued at $31,607,768. Company insiders own 0.28% of the company's stock.

UnitedHealth Group Stock Performance

UNH stock traded down $15.09 during trading on Tuesday, reaching $267.03. 24,386,567 shares of the stock were exchanged, compared to its average volume of 11,472,069. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71. The stock has a 50 day simple moving average of $300.91 and a 200-day simple moving average of $422.56. The company has a market capitalization of $242.23 billion, a P/E ratio of 11.17, a price-to-earnings-growth ratio of 1.39 and a beta of 0.45. UnitedHealth Group Incorporated has a twelve month low of $248.88 and a twelve month high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing analysts' consensus estimates of $5.16 by ($1.08). UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. During the same period last year, the company posted $6.80 earnings per share. The company's quarterly revenue was up 12.9% compared to the same quarter last year. As a group, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, June 24th. Investors of record on Monday, June 16th were paid a $2.21 dividend. This is an increase from UnitedHealth Group's previous quarterly dividend of $2.10. This represents a $8.84 annualized dividend and a yield of 3.31%. The ex-dividend date of this dividend was Monday, June 16th. UnitedHealth Group's dividend payout ratio (DPR) is 37.02%.

Wall Street Analysts Forecast Growth

A number of analysts have issued reports on the company. Wells Fargo & Company cut their target price on UnitedHealth Group from $351.00 to $306.00 and set an "overweight" rating on the stock in a research report on Friday. HSBC restated a "reduce" rating and issued a $270.00 price target (down from $490.00) on shares of UnitedHealth Group in a research note on Wednesday, May 21st. Wall Street Zen lowered UnitedHealth Group from a "buy" rating to a "hold" rating in a research note on Saturday, May 24th. TD Cowen downgraded UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 target price for the company. in a research report on Monday, May 19th. Finally, Erste Group Bank cut UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, April 30th. One analyst has rated the stock with a sell rating, nine have issued a hold rating and fifteen have assigned a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $392.29.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.